rs369887158
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001171613.2(PREPL):c.1510A>T(p.Met504Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000185 in 1,603,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M504I) has been classified as Uncertain significance.
Frequency
Consequence
NM_001171613.2 missense
Scores
Clinical Significance
Conservation
Publications
- hypotonia-cystinuria syndromeInheritance: AR Classification: STRONG Submitted by: G2P
- myasthenic syndrome, congenital, 22Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152034Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000489 AC: 12AN: 245592 AF XY: 0.0000528 show subpopulations
GnomAD4 exome AF: 0.000198 AC: 287AN: 1451964Hom.: 0 Cov.: 31 AF XY: 0.000195 AC XY: 141AN XY: 722424 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152034Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74286 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Myasthenic syndrome, congenital, 22 Uncertain:1
This sequence change replaces methionine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 593 of the PREPL protein (p.Met593Leu). This variant is present in population databases (rs369887158, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with PREPL-related conditions. ClinVar contains an entry for this variant (Variation ID: 478310). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.1777A>T (p.M593L) alteration is located in exon 11 (coding exon 11) of the PREPL gene. This alteration results from a A to T substitution at nucleotide position 1777, causing the methionine (M) at amino acid position 593 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at